Professor Dr. Abdul Jalil Khan, Vice-Chancellor of Khyber Medical University (KMU), Peshawar, has participated in an important World Health Organization (WHO) meeting in Geneva, Switzerland, focused on developing international guidelines for cardiovascular disease prevention and management.
The five-day meeting of the WHO Guideline Development Group was held from October 26 to 30, 2026. It brought together international experts from medical, academic and research institutions to review scientific evidence and develop recommendations for managing dyslipidaemia, a condition involving abnormal levels of fats in the blood.
Professor Abdul Jalil Khan was the only expert selected from Pakistan for the WHO group through an international selection process. His expertise in family medicine, primary healthcare, public health and health systems strengthening contributed to discussions on practical approaches to preventing heart attacks and strokes.
The meeting particularly focused on improving the identification and treatment of dyslipidaemia, which is a major risk factor for cardiovascular diseases. Experts discussed evidence-based recommendations that could be implemented across different healthcare systems, including those in low- and middle-income countries.
Professor Khan also highlighted the importance of strengthening primary healthcare services and ensuring that international health recommendations are practical, accessible and suitable for different communities.
The WHO guidelines are expected to help countries improve cardiovascular disease prevention, clinical decision-making and the management of non-communicable diseases through primary healthcare systems.
His participation also highlights the contribution of Pakistani medical professionals to international health policy and global medical research.
